Large Animal Facility for Imaging and Image-guided Therapies at MSU
Large Animal Facility for Imaging and Image-guided Therapies at MSU
批准号:
10373769
负责人:
ANNA MOORE
金额:
$672.12万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-20 至 2026-05-31
关键词:
Animal Disease ModelsAnimal ExperimentationAnimal ModelAnimalsAreaBiomedical ResearchCanis familiarisCardiovascular DiseasesClientClinicalClinical ResearchClinical TrialsCollaborationsCommunitiesComparative StudyDataDevelopmentDiabetes MellitusDiagnosisDiagnosticDiseaseEarly DiagnosisEquipmentFamily suidaeFundingHealthHealthcareHealthcare SystemsHumanHuman BiologyHuman PathologyImageInstitutionLaboratory AnimalsLengthLinkLongevityMagnetic Resonance ImagingMalignant NeoplasmsMedicineMichiganMolecularMolecular TargetNew AgentsOutcomePathologyPhysiologyPlayPositron-Emission TomographyPrecision HealthPregnancyResearchResearch PersonnelRodentRoleSheepSmall Animal Imaging SystemsTestingTherapeutic AgentsTrainingTranslatingTranslational ResearchUniversitiesanimal facilityanimal imagingbioimagingclinical imagingclinical practiceclinically relevantcollegecompanion animalcomparativehuman diseasehuman modelhuman subjectimage guidedimage guided therapyimaging facilitiesimaging systemin vivo imagingmortalitymultidisciplinarynovel therapeuticspre-clinicalpre-clinical researchprecision medicineprogramssuccesstranslational studyundergraduate student
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Precision health is an emerging paradigm in healthcare that focuses on early detection and molecular
determinants of disease. Michigan State University (MSU) has launched a University-wide initiative to bring the
principles of precision health into its healthcare systems. The success of this initiative depends, in large part, on
our ability to obtain relevant data from predictive pre-clinical animal models and effective translational research.
Advances in molecularly targeted diagnostic and therapeutic agents, the cornerstones of precision medicine,
require reliable testing in informative animal models of human biology. Small laboratory animals (rodents)
commonly used in biomedical research are often not suitable for studying pathologies where physiology, human
markers, physical size, gestation length, lifespan, and other human-like features are key contributors to disease.
Use of larger animal species for research, including dogs, pigs and sheep, can overcome many of these hurdles.
It is widely accepted that in vivo imaging plays a pivotal role in nearly all areas of biomedical research
and clinical practice, and the importance of its role will only increase with the development of new agents and
therapies. However, imaging data obtained in small animal imaging systems cannot always be directly translated
to studies in humans. Clearly, studying large animal models using clinical scanners would produce data that are
closest to what we expect in humans, and would better inform translational studies. Further, the ability to study
comparative diseases that occur spontaneously in domesticated species, as part of clinical studies of client-
owned animals, will add further to translational relevance and data outcomes.
For these reasons and to advance the clinical relevance of animal models, we are requesting funds to
develop a multi-species large animal imaging facility at MSU. This facility will be equipped with a state-of-the-art
high-end clinical imaging system (PET/MRI, mMR Biograph, Siemens) that would serve MSU’s diverse
biomedical scientific and clinical communities. Researchers will use this facility for studies of large research
animals, and client-owned companion animals to develop imaging and image-guided therapy approaches with
focus on human pathologies linked to significant mortality rates (e.g., cardiovascular disease, cancer, and
diabetes). This multidisciplinary facility will also support ongoing clinical trials in human subjects and serve as a
training ground for undergraduate, graduate and postdoctoral trainees from 6 colleges, 12 departments and 7
programs. performing research on a full spectrum of human and animal disease models.
This new biomedical imaging facility, in combination with human and veterinary expertise at MSU, creates
an extraordinary opportunity to perform pre-clinical, clinical and translational research using clinical imaging
equipment. These capabilities will promote high-level collaborations between MSU and investigators at regional
and national institutions to ultimately champion and advance a premiere program in precision health and
comparative medicine, benefiting both human and animal health in the diagnosis and treatment of disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Prostate cancer therapy based on m-aconitase inhibition
-
批准号:10435673
-
项目类别:
-
资助金额:$23.5万
-
财政年份:2022
-
负责人:ANNA MOORE
-
依托单位:
Novel Prostate cancer therapy based on m-aconitase inhibition
-
批准号:10580844
-
项目类别:
-
资助金额:$18.11万
-
财政年份:2022
-
负责人:ANNA MOORE
-
依托单位:
Therapy for Metastatic breast cancer based on micro RNA silencing
-
批准号:10434241
-
项目类别:
-
资助金额:$58.03万
-
财政年份:2021
-
负责人:ANNA MOORE
-
依托单位:
anti-miR-10b Nanodrug for Treatment of Breast Cancer Metastasis: Study in Companion Animals
-
批准号:10659027
-
项目类别:
-
资助金额:$55.69万
-
财政年份:2021
-
负责人:ANNA MOORE
-
依托单位:
anti-miR-10b Nanodrug for Treatment of Breast Cancer Metastasis: Study in Companion Animals
-
批准号:10450168
-
项目类别:
-
资助金额:$55.69万
-
财政年份:2021
-
负责人:ANNA MOORE
-
依托单位:
Therapy for Metastatic breast cancer based on micro RNA silencing
-
批准号:10489811
-
项目类别:
-
资助金额:$55.53万
-
财政年份:2021
-
负责人:ANNA MOORE
-
依托单位:
anti-miR-10b Nanodrug for Treatment of Breast Cancer Metastasis: Study in Companion Animals
-
批准号:10265643
-
项目类别:
-
资助金额:$56.82万
-
财政年份:2021
-
负责人:ANNA MOORE
-
依托单位:
Therapy for Metastatic breast cancer based on micro RNA silencing
-
批准号:9979793
-
项目类别:
-
资助金额:$58.65万
-
财政年份:2018
-
负责人:ANNA MOORE
-
依托单位:
Therapy for Metastatic breast cancer based on micro RNA silencing
-
批准号:9753181
-
项目类别:
-
资助金额:$56.89万
-
财政年份:2018
-
负责人:ANNA MOORE
-
依托单位:
siRNA Protection of Composite Islet Kidney Transplant in Baboons
-
批准号:8970851
-
项目类别:
-
资助金额:$59.27万
-
财政年份:2015
-
负责人:ANNA MOORE
-
依托单位:
siRNA Protection of Composite Islet Kidney Transplant in Baboons
-
批准号:9285795
-
项目类别:
-
资助金额:$47.37万
-
财政年份:2015
-
负责人:ANNA MOORE
-
依托单位:
siRNA Protection of Islet Grafts in Baboons
-
批准号:9619130
-
项目类别:
-
资助金额:$10.74万
-
财政年份:2015
-
负责人:ANNA MOORE
-
依托单位:
siRNA Protection of Islet Grafts in Baboons
-
批准号:9285782
-
项目类别:
-
资助金额:$39.71万
-
财政年份:2015
-
负责人:ANNA MOORE
-
依托单位:
Targeted therapy in Type 1 diabetes
-
批准号:8582877
-
项目类别:
-
资助金额:$68.22万
-
财政年份:2013
-
负责人:ANNA MOORE
-
依托单位:
Targeted therapy in Type 1 diabetes
-
批准号:8703684
-
项目类别:
-
资助金额:$67.03万
-
财政年份:2013
-
负责人:ANNA MOORE
-
依托单位:
Combined siRNA Therapy and In-vivo Imaging in Islet Transplantation
-
批准号:8001143
-
项目类别:
-
资助金额:$5.13万
-
财政年份:2010
-
负责人:ANNA MOORE
-
依托单位:
IVIS Spectrum Imaging System
-
批准号:7595434
-
项目类别:
-
资助金额:$34.11万
-
财政年份:2009
-
负责人:ANNA MOORE
-
依托单位:
Multi-Parameter Monitoring of Breast Cancer Progression and Therapeutic Response
-
批准号:8150475
-
项目类别:
-
资助金额:$48.83万
-
财政年份:2008
-
负责人:ANNA MOORE
-
依托单位:
Combined siRNA Therapy and In-vivo Imaging in Islet Transplantation
-
批准号:7661584
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2008
-
负责人:ANNA MOORE
-
依托单位:
Predictive Cancer Diagnostics and Therapy Response
-
批准号:8791305
-
项目类别:
-
资助金额:$55.24万
-
财政年份:2008
-
负责人:ANNA MOORE
-
依托单位:
海外基金